Skip to main content
Clinical Trials/NCT03333772
NCT03333772CompletedNot Applicable

Feasibility of a Complex Behavioral Intervention for Young Adults With Diabetes: The Resilient, Empowered, Active Living-Telehealth (REAL-T) Study

University of Southern California1 site in 1 country8 target enrollmentStarted: November 15, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
8
Locations
1
Primary Endpoint
Feasibility

Study Overview

Brief Summary

Feasibility of a Complex Behavioral Intervention for Young Adults with Diabetes: The Resilient, Empowered, Active Living-Telehealth (REAL-T) Study will evaluate the feasibility of implementing a diabetes management intervention via telehealth in preparation for a large-scale randomized controlled trial (RCT) entitled Evaluation of a Complex Behavioral Intervention for Young Adults with Diabetes: The Resilient, Empowered, Active Living-Telehealth (REAL-T) Study.

Detailed Description

Feasibility of a Complex Behavioral Intervention for Young Adults with Diabetes: The Resilient, Empowered, Active Living-Telehealth (REAL-T) feasibility study will evaluate the feasibility of implementing a diabetes management intervention via telehealth in preparation for a large-scale RCT.

Young adulthood is a challenging life stage for many individuals with diabetes; only 17% of YAs age 18-25 and 30% age 26-30 attain recommended A1C targets, and fewer than 1/3 perform self-care in accordance with national guidelines. Yet, it is a crucial stage for establishing health habits that persist throughout adulthood. To address these issues, our research team developed REAL Diabetes (Resilient, Empowered, Active Living with Diabetes), a 6-month individually tailored occupational therapy intervention focused on incorporating diabetes self-care into participants' daily habits and routines, and evaluated its efficacy in a pilot randomized controlled trial (n=81). REAL was shown in intention-to-treat analysis to significantly improve A1C (0.9% reduction; p=0.01) and diabetes-related quality of life (p=0.04). While REAL was highly promising in terms of its positive impact on health and quality of life, the intervention was delivered through home visits, limiting its potential for broad dissemination. Given that our target population experiences significant logistical barriers to clinic attendance (the impetus for our in-home treatment model), we therefore will adapt REAL to be delivered via telehealth (REAL-T), a highly promising care delivery model, and evaluate REAL-T in a large-scale RCT.

The current feasibility study will evaluate the feasibility of implementing the REAL-T intervention via telehealth by enrolling 10 participants who are 18-30 years of age, conducting the REAL-T intervention with all participants over a 3-month period, and assessing the process of implementing the study (feasibility and participant satisfaction).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosed with either type 1 diabetes or type 2 diabetes for at least 12 months
  • •Hemoglobin A1C >7.5%
  • •Resident of Los Angeles County with no imminent plans to relocate
  • •Fluent in English
  • •Previous participant in REAL Diabetes Study

Exclusion Criteria

  • •Pregnant or planning to become pregnant within the next 4 months
  • •Diagnosed with a comorbid cognitive or intellectual disability

Arms & Interventions

REAL-T Intervention

Experimental

The current feasibility study will evaluate the feasibility of implementing the REAL-T RCT by enrolling 10 participants who are 18-30 years of age, conducting the REAL-T intervention with all participants over a 3-month period, evaluating pre-to-post changes in their health and quality of life, and assessing the process of implementing the study (feasibility and participant satisfaction).

Intervention: REAL-T Intervention (Behavioral)

Outcomes

Primary Outcomes

Feasibility

Time Frame: 3 months

Both formative and summative data will be gathered throughout the study to assess feasibility, defined herein as the extent to which the intervention can be successfully delivered via telehealth. Feasibility will be assessed through surveys.

Acceptability

Time Frame: 3 months

Both formative and summative data will be gathered throughout the study to assess acceptability, defined herein as the perception of the intervention as agreeable/satisfactory. Acceptability will be assessed through interviews.

Secondary Outcomes

  • Change from baseline in Patient Health Questionnaire-8 (PHQ-8) survey at post-intervention(Baseline, 3 months)
  • Change from baseline in Audit of Diabetes-Dependent Quality of Life (ADD-QoL) at post-intervention(Baseline, 3 months)
  • Change from baseline in The Diabetes Empowerment Scale-Short Form (DES-SF) at post-intervention(Baseline, 3 months)
  • Change from baseline in Problem Areas in Diabetes (PAID) survey at post-intervention(Baseline, 3 months)
  • Change from baseline in Summary of Diabetes Self-Care Activities (SDSCA) at post-intervention(Baseline, 3 months)
  • Change from baseline in Glycated hemoglobin (HbA1C) at post-intervention(Baseline, 3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Elizabeth Pyatak

Assistant Professor

University of Southern California

Study Sites (1)

Loading locations...

Similar Trials

Feasibility of Delivering a Complex... | Clinical Trial